Position in AMGN
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$16,387,378
+$686,776 QoQ
Shares Held
45,254
+1.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#420
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gradient Investments LLC holds $135,016,826 across 9 Drug Manufacturers - General names. AMGN ranks #5 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
152,831 | $38,814,489 | |
| 2 | LLY |
ELI LILLY & Co
|
27,342 | $32,794,817 | |
| 3 | AZN |
Astrazeneca PLC
|
108,133 | $20,504,179 | |
| 4 | ABBV |
AbbVie Inc.
|
77,648 | $19,539,342 | |
| 5 | AMGN |
Amgen Inc
This page
|
45,254 | $16,387,378 | |
| 6 | NVS |
Novartis AG
|
37,294 | $5,844,715 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,723 | $478,405 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,854 | $337,307 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,387,378 | 45,254 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $15,700,602 | 44,623 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $15,108,629 | 46,160 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $13,418,892 | 47,551 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $13,188,763 | 47,236 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $14,627,584 | 46,951 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $12,902,983 | 49,505 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $13,020,506 | 40,410 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $17,091,327 | 54,701 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $16,216,475 | 57,036 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $17,966,111 | 62,378 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $17,603,242 | 65,498 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,090,340 | 4,911 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $1,179,740 | 4,880 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,281,945 | 4,881 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $1,098,825 | 4,875 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,012,128 | 4,160 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $15,403,208 | 63,697 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $13,930,592 | 61,922 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $11,873,950 | 55,838 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $12,181,650 | 49,976 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $11,576,880 | 46,529 | Shares | Sole | 2021-04-21 | |
| 2020-12-31 | $9,758,954 | 42,445 | Shares | Sole | 2021-01-08 | |
| 2020-09-30 | $10,936,250 | 43,029 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $10,225,710 | 43,355 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $9,631,296 | 47,508 | Shares | Sole | 2020-04-07 | |
| No filing history on record for this holder in this stock. | ||||||